Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT04901767
Eligibility Criteria:
Inclusion Criteria:
* Participant is willing and able to give informed consent for participation in the study.
* Male or Female, aged 18 years or above.
* Been treated with percutaneous coronary intervention of either drug coated balloon or drug eluting stent
Exclusion Criteria:
* Any contraindications to administration of acetylcholine or GTN
* History of coronary vasospasm or spontaneous coronary artery dissection
* Significant medical, surgical or psychiatric disease that would affect subject safety or influence the study outcome according to physician's opinion
* Patients who received a combination of drug eluting stents and drug coated balloon to the same vessel
* Significant renal impairment (estimated glomerular filtration rate \<30mL/min/ 1.73m2
* Body mass index \>35 (may affect coronary artery diameter qualitative assessment)
* Symptomatic congestive cardiac failure
* Severe asthma
* Significant autoimmune inflammatory conditions (for example rheumatoid arthritis)
* Patients taking immunomodulating drugs (including Methotrexate, Ciclosporin, steroids)
* Previous heart transplant
* Relative Anaemia - Haemoglobin \<12g/dL in men and \<10g/dL in women
* Women of child bearing age with a positive pregnancy test
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04901767
Study Brief:
Protocol Section:
NCT04901767